-
Henan Grave Carved with Herbal Prescriptions Draws Hundreds of Visitors Daily
-
Masdar Completes $950M Lockhart Solar and Storage Project in California
-
USMNT Coaching Search: Guardiola, Cherundolo, and Others Named as Pochettino Replacements
-
Mansa’s AI Microdrama Sparks Debate Over Black Representation in Hollywood
-
SDF Intelligence Unit Avoided Classifying Civilian Data as Public Records
-
Microsoft Outage Disrupts Outlook and Teams for Hours Globally
-
Inflation Breach and Bond Yields Spark Rate Hike Fears for December
-
RSC’s ‘Julius Caesar’ Reimagined in Women’s Prison Setting for School Tour
-
Documentary Reveals How Screams Exposed Alleged Camgirl Exploitation Ring
-
Korea Reviews GLP-1 Vision Loss Warnings Following US FDA Action
-
Road Access Completed Drill Program to Begin
-
ACCESS Newswire Continues to Repurchase its Shares
-
Greenwich LifeSciences Interview to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
-
Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates
-
Xenetic Biosciences Reports Third Quarter 2026 Financial Results and Highlights Strategic Business Updates
-
Does IRS Debt Expire? Clear Start Tax Explains the 10-Year Collection Statute and What Quietly Resets It
-
GameSquare's Hatchet Publishes TikTok Live for Gaming in H1 2026 Report
-
Arrive AI Reports Third Quarter 2026 Results Highlighted by Revenue Growth and Expanded Partnerships
-
Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q2
-
Mako Mining Reports Q3 2026 Financial Results, Including Adjusted EBITDA(1) of US$30.3 million and EPS of US$0.19/share
-
eXoZymes to Host Third Quarter 2026 update Conference Call on Thursday, November 19, 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 13
-
How Families Plan and Save for Holiday Travel
-
Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
-
Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario
-
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
-
Rifstone Capital LLC Advances Institutional Research Platform with Expanded Global Allocation Framework
-
SMX Puts American Innovation to Work in the New Era of Artificial Intelligence
-
Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
-
Foundation Software Explores How Contractors Can Prepare for the AI-Driven Construction Boom
-
Trustpoint Xposure Launches Program to Help Startup Founders Check How AI Search Platforms Describe Their Companies
-
DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
-
MARS Energy Group Adds Jigar Shah to Advisory Board to Accelerate Battery Storage Growth
-
The Epomaker Alice40 Brings Mahjong Sound and Sunset Style to Ergonomic Typing
-
SMX Brings American Ingenuity to the Next Frontier of Artificial Intelligence
-
Jane Maciver Joins Fragrance Creators Board
-
Below Deck alumnus João Franco and brother arrested after fatal Turkey fight
-
Ole Miss inquiry expands after video and monkey-noise allegations
-
General Hospital actor Randall England dies at 75
-
Argentina Inflation Rises to 2.2% in October Amid Core Price Decline
-
Bunnie XO artwork taken down from Jelly Roll’s Nashville bar
-
London museum removes Russell Brand hair exhibit after rape conviction
-
NRC Approves Construction of Advanced Nuclear Reactors at Texas Petrochemical Site
-
Arlington sentinel rebukes Pete Hegseth entourage for laughter near memorial
-
Yella Beezy sentenced to life for arranging rapper Mo3’s murder
-
Kylie Jenner employee describes closet ordeal and pepper-spray incident
-
Xi Jinping Urges Unity and Reunification at Sun Yat-sen Anniversary
CTT Pharma Gives Uplisting Update
TAMPA, FLORIDA / ACCESS Newswire / March 3, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) is expecting notification this week for uplisting status to the OTCQB. CTT will notify shareholders as more news becomes available.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
W.Stewart--AT